Pure Global AI
CDSCO UID IMP/IVD/2022/000152_f87c98ac0c3bb29f5b5c988d953aa8c6_733ed5bac398722348a1cefec9831e75

Anti-Nucleosomes ELISA

M/s. CPC Diagnostics Pvt LtdDevice Class Class BIndia CDSCOBrand: NIL
VerifiedCDSCO · official registry
Registration details
UID
IMP/IVD/2022/000152_f87c98ac0c3bb29f5b5c988d953aa8c6_733ed5bac398722348a1cefec9831e75
Device class
Class B
Brand name
NIL
Approving authority
CDSCO
Product information
The enzyme immunoassay (NIL) provides semiquantitative or quantitative in vitro determination of human antibodies of the immunoglobulin class IgG against nucleosomes in serum or plasma to support the diagnosis of systemic lupus erythematosus
About this record

Anti-Nucleosomes ELISA is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000152_f87c98ac0c3bb29f5b5c988d953aa8c6_733ed5bac398722348a1cefec9831e75. This device is marketed under the brand name NIL. The license holder is M/s. CPC Diagnostics Pvt Ltd, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides the facts attached to this CDSCO registry row. Other records from the same license holder are available through the database search link without adding aggregation queries to this page. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.